Company Filing History:
7 out of 3,684 
3 out of 38 Years Active: 2016-2024
Title: The Innovative Journey of Inventor Steven Sheriff
Introduction
Steven Sheriff, an accomplished inventor located in Princeton, NJ, has made significant contributions to the field of biomedicine with a total of seven patents to his name. His work focuses primarily on antibodies and antigen binding peptides, showcasing his dedication to advancing therapeutic solutions for various medical conditions.
Latest Patents
Among Steven's noteworthy inventions are his latest patents that tackle critical issues in medicine. One of these patents, titled "Antibodies and Antigen Binding Peptides for Factor XIa Inhibitors and Uses Thereof," presents novel antigen binding peptides that specifically target selective FXIa inhibitors. This invention not only proposes a method for reducing the antithrombotic effects of these inhibitors but also introduces detection reagents for monitoring their levels in biological samples. Another important patent, "IP-10 Antibodies and Their Uses," describes isolated monoclonal antibodies that bind to IP-10 with high affinity, aiming to treat various inflammatory and autoimmune diseases by inhibiting IP-10 activity.
Career Highlights
Steven Sheriff has built a robust career in the pharmaceutical industry. He has worked with renowned companies such as Bristol-Myers Squibb Company and Domantis Limited, where he has contributed to groundbreaking research and development in drug innovations. His expertise in the field is reflected through the patents he has been granted, emphasizing the practical applications of his work.
Collaborations
Throughout his career, Steven has collaborated with esteemed coworkers including Anish Suri and Suzanne J. Suchard. These partnerships reflect a collaborative spirit within the research community, crucial for driving innovations that have the potential to change the landscape of medical treatments.
Conclusion
With seven patents under his belt, Steven Sheriff continues to be a significant contributor to biomedical innovation. His groundbreaking work on antibodies and antigen binding peptides not only holds promise for future therapeutic strategies but also solidifies his status as a leading inventor in the field. His ongoing efforts will undoubtedly inspire future advancements in the medical sciences.